Microenterprise Intervention to Reduce Sexual Risk Behaviors and Increase Employment and HIV Preventive Practices Among Economically-Vulnerable African-American Young Adults (EMERGE): A Feasibility Randomized Clinical Trial

Larissa Jennings Mayo-Wilson, Jessica Coleman, Fatmata Timbo, Fred M Ssewamala, Sebastian Linnemayr, Grace T Yi, Bee-Ah Kang, Matthew W Johnson, Gayane Yenokyan, Brian Dodge, Nancy E Glass, Larissa Jennings Mayo-Wilson, Jessica Coleman, Fatmata Timbo, Fred M Ssewamala, Sebastian Linnemayr, Grace T Yi, Bee-Ah Kang, Matthew W Johnson, Gayane Yenokyan, Brian Dodge, Nancy E Glass

Abstract

Economic vulnerability, such as homelessness and unemployment, contributes to HIV risk among U.S. racial minorities. Yet, few economic-strengthening interventions have been adapted for HIV prevention in this population. This study assessed the feasibility of conducting a randomized clinical trial of a 20-week microenterprise intervention for economically-vulnerable African-American young adults. Engaging MicroenterprisE for Resource Generation and Health Empowerment (EMERGE) aimed to reduce sexual risk behaviors and increase employment and uptake of HIV preventive behaviors. The experimental group received text messages on job openings plus educational sessions, mentoring, a start-up grant, and business and HIV prevention text messages. The comparison group received text messages on job openings only. Primary feasibility objectives assessed recruitment, randomization, participation, and retention. Secondary objectives examined employment, sexual risk behaviors, and HIV preventive behaviors. Outcome assessments used an in-person pre- and post-intervention interview and a weekly text message survey. Several progression criteria for a definitive trial were met. Thirty-eight participants were randomized to experimental (n = 19) or comparison group (n = 19) of which 95% were retained. The comparison intervention enhanced willingness to be randomized and reduced non-participation. Mean age of participants was 21.0 years; 35% were male; 81% were unemployed. Fifty-eight percent (58%) of experimental participants completed ≥ 70% of intervention activities, and 74% completed ≥ 50% of intervention activities. Participation in intervention activities and outcome assessments was highest in the first half (~ 10 weeks) of the study. Seventy-one percent (71%) of weekly text message surveys received a response through week 14, but responsiveness declined to 37% of participants responding to ≥ 70% of weekly text message surveys at the end of the study. The experimental group reported higher employment (from 32% at baseline to 83% at week 26) and lower unprotected sex (79% to 58%) over time compared to reported changes in employment (37% to 47%) and unprotected sex (63% to 53%) over time in the comparison group. Conducting this feasibility trial was a critical step in the process of designing and testing a behavioral intervention. Development of a fully-powered effectiveness trial should take into account lessons learned regarding intervention duration, screening, and measurement.Trial Registration ClinicalTrials.gov. NCT03766165. Registered 04 December 2018. https://ichgcp.net/clinical-trials-registry/NCT03766165.

Keywords: African-American; Baltimore; Clinical trial; Economic; Feasibility; HIV; Homeless; Sexual risk behaviors; Text messages; Unemployment; Young adults.

Conflict of interest statement

The authors declare that they have no competing interests.

Figures

Fig. 1
Fig. 1
Participant flow diagram
Fig. 2
Fig. 2
Summary of components of the 20-Week EMERGE experimental intervention

References

    1. Denning P, DiNenno E. UNAIDS and Centers for Disease Control and Prevention. Communities in crisis: is there a generalized HIV epidemic in impoverished urban areas of the United States? (2019). Accessed
    1. CDC HIV prevalence estimates—United States. MMWR. 2008;57:1073–1076.
    1. Maryland HIV Progress Report (2017). Accessed
    1. Baltimore City Annual HIV Epidemiological Profile 2017. Center for HIV Surveillance, Epidemiology and Evaluation, Maryland Department of Health. Baltimore. (2018). Accessed
    1. Centers of Disease Control and Prevention. Estimated HIV incidence and prevalence in the United States, 2010–2015. HIV Surveill Suppl Rep 2018; 23(1).
    1. Barnett T. HIV/AIDS prevention: hope for a new paradigm? Development. 2007;50(2):70–75.
    1. Dinkelman T, Lam D, Leibbrandt M. Household and community income, economic shocks and risky sexual behavior of young adults: evidence from the Cape Area Panel Study 2002 and 2005. Aids. 2007;21(Suppl 7):S49–56.
    1. Campbell C. Letting them die: why HIV/AIDS intervention programmes fail. Bloomington: Indiana University Press; 2003.
    1. Jennings L. Do men need empowering too? A systematic review of entrepreneurial education and microenterprise development on health disparities among inner-city black male youth. J Urban Health. 2014;91(5):836–850.
    1. Ssewamala FM, Han CK, Neilands TB, Ismayilova L, Sperber E. Effect of economic assets on sexual risk-taking intentions among orphaned adolescents in Uganda. Am J Public Health. 2010;100(3):483–488.
    1. Ssewamala FM, Ismayilova L, McKay M, Sperber E, Bannon W, Jr, Alicea S. Gender and the effects of an economic empowerment program on attitudes toward sexual risk-taking among AIDS-orphaned adolescent youth in Uganda. J Adolesc Health. 2010;46(4):372–378. doi: 10.1016/j.jadohealth.2009.08.010.
    1. Jennings L, Ssewamala F, Nabunya P. Effect of savings-led economic empowerment on HIV preventive practices among AIDS-orphaned adolescents in rural Uganda: results from the Suubi-Maka randomized experiment. AIDS Care. 2016;28(3):273–282.
    1. Kim J, Ferrari G, Abramsky T, et al. Assessing the incremental effects of combining economic and health interventions: the IMAGE study in South Africa. Bull World Health Org. 2009;87(11):824–832.
    1. Odek WO, Busza J, Morris CN, Cleland J, Ngugi EN, Ferguson AG. Effects of micro-enterprise services on HIV risk behaviour among female sex workers in Kenya's urban slums. AIDS Behav. 2009;13(3):449–461.
    1. Pronyk PM, Kim JC, Abramsky T, et al. A combined microfinance and training intervention can reduce HIV risk behaviour in young female participants. Aids. 2008;22(13):1659–1665.
    1. Rosenberg MS, Seavey BK, Jules R, Kershaw TS. The role of a microfinance program on HIV risk behavior among Haitian women. AIDS Behav. 2011;15(5):911–918.
    1. Sherman SG, Srikrishnan AK, Rivett KA, Liu SH, Solomon S, Celentano DD. Acceptability of a microenterprise intervention among female sex workers in Chennai, India. AIDS Behav. 2010;14(3):649–657.
    1. Sherman SG, German D, Cheng Y, Marks M, Bailey-Kloche M. The evaluation of the JEWEL project: an innovative economic enhancement and HIV prevention intervention study targeting drug using women involved in prostitution. AIDS Care. 2006;18(1):1–11.
    1. Raj A, Dasgupta A, Goldson I, Lafontant D, Freeman E, Silverman JG. Pilot evaluation of the Making Employment Needs [MEN] count intervention: addressing behavioral and structural HIV risks in heterosexual black men. AIDS Care. 2014;26(2):152–159.
    1. Dunbar MS, Kang Dufour MS, Lambdin B, Mudekunye-Mahaka I, Nhamo D, Padian NS. The SHAZ! project: results from a pilot randomized trial of a structural intervention to prevent HIV among adolescent women in Zimbabwe. PLoS ONE. 2014;9(11):e113621.
    1. Cui RR, Lee R, Thirumurthy H, Muessig KE, Tucker JD. Microenterprise development interventions for sexual risk reduction: a systematic review. AIDS Behav. 2013;17(9):2864–2877.
    1. Jennings L, Shore D, Strohminger N, Burgundi A. Entrepreneurial development for US minority homeless youth: a qualitative inquiry on value, barriers, and impact on health. Child Youth Serv Rev. 2015;49:39–47.
    1. Jennings L, Lee N, Shore D, Strohminger N, Burgundi A, Conserve DF, Cheskin LJUS. minority homeless youth’s access to and use of mobile phones: implications for mHealth intervention design. J Health Commun. 2016;21(7):725–733.
    1. Reback CJ, Fletcher JB, Shoptaw S, Mansergh G. Exposure to theory-driven text messages is associated with HIV risk reduction among methamphetamine-using men who have sex with men. AIDS Behav. 2015;19(Suppl 2):130–141.
    1. Pérez-Sánchez IN, Candela Iglesias M, Rodriguez-Estrada E, Reyes-Terán G, Caballero-Suárez NP. Design, validation and testing of short text messages for an HIV mobile-health intervention to improve antiretroviral treatment adherence in Mexico. AIDS Care. 2018;30(sup1):37–43.
    1. Lester RT, Ritvo P, Mills EJ, Kariri A, Karanja S, Chung MH, Jack W, Habyarimana J, Sadatsafavi M, Najafzadeh M, Marra CA, Estambale B, Ngugi E, Ball TB, Thabane L, Gelmon LJ, Kimani J, Ackers M, Plummer FA. Effects of a mobile phone short message service on antiretroviral treatment adherence in Kenya (WelTel Kenya1): a randomised trial. Lancet. 2010;376(9755):1838–1845.
    1. Garofalo R, Kuhns LM, Hotton A, Johnson A, Muldoon A, Rice D. A Randomized controlled trial of personalized text message reminders to promote medication adherence among hiv-positive adolescents and young adults. AIDS Behav. 2016;20(5):1049–1059.
    1. Leon AC, Davis LL, Kraemer HC. The role and interpretation of pilot studies in clinical research. J Psychiatr Res. 2011;45(5):626–629. doi: 10.1016/j.jpsychires.2010.10.008.
    1. Eldridge SM, Lancaster GA, Campbell MJ, Thabane L, Hopewell S, Coleman CL, Bond CM. Defining feasibility and pilot studies in preparation for randomised controlled trials: development of a conceptual framework. PLoS ONE. 2016;11(3):e0150205.
    1. Bowen DJ, Kreuter M, Spring B, Cofta-Woerpel L, Linnan L, Weiner D, Bakken S, Kaplan CP, Squiers L, Fabrizio C, Fernandez M. How we design feasibility studies. Am J Prev Med. 2009;36(5):452–457.
    1. Jennings Mayo-Wilson L, Coleman J, Timbo F, Brown ERT, Butler AI, Conserve DF, Glass NE. Acceptability of a feasibility randomized clinical trial of a microenterprise intervention to reduce sexual risk behaviors and increase employment and HIV preventive practices (EMERGE) in young adults: a mixed methods assessment. Manuscript Under Review.
    1. Grant S, Mayo-Wilson E, Montgomery P, Macdonald G, Michie S, Hopewell S, Moher D, On behalf of the CONSORT-SPI group CONSORT-SPI 2018 explanation and elaboration: guidance for reporting social and psychological intervention trials. Trials. 2018;19(1):406.
    1. Eldridge SM, Chan CL, Campbell MJ, Bond CM, Hopewell S, Thabane L, Lancaster GA, PAFS consensus group CONSORT 2010 statement: extension to randomised pilot and feasibility trials. BMJ. 2016;355:5239.
    1. Jennings Mayo-Wilson L, Glass NE, Ssewamala FM, Linnemayr S, Coleman J, Timbo F, Johnson MW, Davoust M, Labrique A, Yenokyan G, Dodge B, Latkin C. Microenterprise intervention to reduce sexual risk behaviors and increase employment and HIV preventive practices in economically-vulnerable African-American young adults (EMERGE): protocol for a feasibility randomized clinical trial. Trials. 2019;20(1):439.
    1. Desai AS, Solomon S, Claggett B, McMurray JJ, Rouleau J, Swedberg K, Zile M, Lefkowitz M, Shi V, Packer M. Factors associated with noncompletion during the run-in period before randomization and influence on the estimated benefit of LCZ696 in the PARADIGM-HF Trial. Circ Heart Fail. 2016;9(6):e002735.
    1. Bowry R, Parker S, Rajan SS, Yamal JM, Wu TC, Richardson L, Noser E, Persse D, Jackson K, Grotta JC. Benefits of stroke treatment using a mobile stroke unit compared with standard management: the BEST-MSU study run-in phase. Stroke. 2015;46(12):3370–3374.
    1. Suissa S. Run-in bias in randomised trials: the case of COPD medications. Eur Respir J. 2017;49(6):1700361.
    1. Fukuoka Y, Gay C, Haskell W, Arai S, Vittinghoff E. Identifying factors associated with dropout during pre-randomization run-in period from an mHealth physical activity education study: the mPED Trial. JMIR Mhealth Uhealth. 2015;3(2):e34.
    1. Schechtman KB. Run-in periods in randomized clinical trials. J Card Fail. 2017;23(9):700–701.
    1. Rees JR, Mott LA, Barry EL, Baron JA, Figueiredo JC, Robertson DJ, Bresalier RS, Peacock JL. Randomized controlled trials: who fails run-in? Trials. 2016;29(17):374.
    1. Arain M, Campbell MJ, Cooper CL, Lancaster GA. What is a pilot or feasibility study? A review of current practice and editorial policy. BMC Med Res Methodol. 2010;10:67.
    1. Julious SA. Sample size of 12 per group rule of thumb for a pilot study. Pharm Stat. 2005;4:287–291.
    1. Lancaster GA, Dodd S, Williamson PR. Design and analysis of pilot studies: recommendations for good practice. J Eval Clin Pract. 2004;10:307–312.
    1. Pile V, Smith P, Leamy M, Blackwell SE, Meiser-Stedman R, Stringer D, Ryan EG, Dunn BD, Holmes EA, Lau JYF. A brief early intervention for adolescent depression that targets emotional mental images and memories: protocol for a feasibility randomised controlled trial (IMAGINE trial) Pilot Feasibility Stud. 2018;4(4):97.
    1. O'Gara B, Marcantonio ER, Pascual-Leone A, Shaefi S, Mueller A, Banner-Goodspeed V, Talmor D, Subramaniam B. Prevention of Early Postoperative Decline (PEaPoD): protocol for a randomized, controlled feasibility trial. Trials. 2018;19(1):676.
    1. Barrett E, Gillespie P, Newell J, Casey D. Feasibility of a physical activity programme embedded into the daily lives of older adults living in nursing homes: protocol for a randomised controlled pilot feasibility study. Trials. 2018;19(1):461.
    1. Steffens D, Young J, Beckenkamp PR, Ratcliffe J, Rubie F, Ansari N, Pillinger N, Solomon M. Feasibility and acceptability of PrE-operative Physical Activity to improve patient outcomes After major cancer surgery: study protocol for a pilot randomised controlled trial (PEPA Trial) Trials. 2018;19(1):112.
    1. Fukuoka Y, Gay C, Haskell W, Arai S, Vittinghoff E. Identifying factors associated with dropout during prerandomization run-in period from an mHealth physical activity education study: the mPED Trial. JMIR Mhealth Uhealth. 2015;3(2):e34.
    1. Norris M, Poltawski L, Calitri R, Shepherd AI, Dean SG, ReTrain Team Hope and despair: a qualitative exploration of the experiences and impact of trial processes in a rehabilitation trial. Trials. 2019;20(1):525. doi: 10.1186/s13063-019-3633-8.
    1. McCambridge J, Sorhaindo A, Quirk A, Nanchahal K. Patient preferences and performance bias in a weight loss trial with a usual care arm. Patient Educ Couns. 2014;95:243–247.
    1. Swann M. Economic strengthening for HIV prevention and risk reduction: a review of the evidence. AIDS Care. 2018;30(sup3):37–84. doi: 10.1080/09540121.2018.1479029.

Source: PubMed

Sponsoren und Mitarbeiter

Krankheiten

Drogeninterventionen

3
Abonnieren